NR3C1 and breast carcinoma: This finding suggests that GR expression in tumoral cells and in nontransformed cells associated with tumors contributes to the biological function of breast cancer, and a detailed analysis of GC signaling could reveal genes that drive breast cancer and identify therapeutic targets [30].